/
you're reading...

Zoetis Receives European Commission Marketing Authorization for APOQUEL® chewable tablets (oclacitinib) for the treatment of itch and inflammation in allergic dogs

A Convenient Solution to Rapidly and Safely Stop the Cycle of Pruritus in Allergic Dogs and Clinical Signs of Atopic Dermatitis in DogsZoetis announced that the European Commission (EC) has granted th...

Read full story

Archives